LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-04-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
Quality control for NMN typically checks identity, assay purity, residual solvents, heavy metals, and microbial limits, depending on the intended use and market. A certificate of analysis may report appearance, solubility, water content, and storage recommendations. Independent verification can compare chromatographic retention time and mass spectrum against a certified reference standard. Regulatory expectations differ between research chemicals, dietary ingredients, and pharmaceutical products. Impurity profiles and stability data are often requested for product approval, and open questions remain about how best to standardize NMN measurements across laboratories.
NMN is a polar, water-soluble nucleotide. In solid form it is usually a white to off-white powder. The compound is sensitive to heat, light, moisture, and extremes of pH, and aqueous solutions tend to degrade faster than dry material. Recommended storage for research samples is typically -20 °C or below in a sealed, desiccated container protected from light. Repeated freeze-thaw cycles should be avoided, and these handling practices help maintain identity and purity during laboratory use.
Analytical identification of NMN commonly uses high-performance liquid chromatography with ultraviolet detection, liquid chromatography-mass spectrometry, and nuclear magnetic resonance spectroscopy; HPLC can estimate purity by peak area, while mass spectrometry confirms molecular mass and fragmentation. NMR provides structural confirmation. Because NMN is charged, ion-pairing reagents or hydrophilic interaction liquid chromatography columns can improve retention and peak shape. In biological samples, LC-MS/MS with stable isotope internal standards is often used to quantify NMN and related NAD+ metabolites. Method validation is important because matrix effects and rapid enzymatic interconversion can complicate measurements.
Quality control for NMN materials usually covers identity, assay purity, residual solvents, heavy metals, microbial limits, and moisture content. Certificates of analysis from suppliers may report high-performance liquid chromatography purity, mass spectrometry identity, and elemental impurity testing. Regulatory treatment differs by country: NMN is not an approved drug, and its status as a dietary supplement ingredient or novel food has been debated. Some authorities have restricted sales pending safety and regulatory review, while others allow it under specific categories. Buyers should verify documentation rather than rely on label claims.
Quantifying NMN requires methods that separate it from structurally similar compounds such as nicotinamide, nicotinamide riboside, and NAD+. Common approaches include high-performance liquid chromatography coupled with ultraviolet detection, liquid chromatography with tandem mass spectrometry, capillary electrophoresis, and nuclear magnetic resonance for identity confirmation. Because NMN is polar and often present at low concentrations in biological samples, sample preparation can involve protein precipitation, solid-phase extraction, or derivatization. Isotope-labeled internal standards help correct for matrix effects and recovery losses. Reported concentrations depend heavily on the matrix, extraction protocol, and analytical platform.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Typical for solid free acid or salt forms |
| Solubility | Freely soluble in water | Polar nucleotide; limited solubility in nonpolar solvents |
| Typical storage | -20 °C or below | Desiccated, protected from light |
| Common analytical method | LC-MS or HPLC-UV | Used for identity and purity assessment |
| Common synonyms | Nicotinamide ribonucleotide; beta-NMN | NMN is the usual abbreviation |
Commercial NMN is produced through enzymatic or chemical routes, and the resulting material can vary in purity, counterion, and residual solvent content. Buyers typically rely on certificates of analysis, but independent verification through third-party laboratories provides stronger assurance. Regulatory treatment differs by country; in the United States, NMN has been subject to shifting guidance about its status as a dietary supplement, while other markets permit sales under local rules. No universal pharmacopeial monograph exists for NMN, so specifications often come from suppliers, research protocols, or regional requirements.
Solid NMN is generally handled as a moisture-sensitive compound. Dry material stored desiccated at low temperature, protected from light, tends to remain stable for extended periods. Aqueous solutions are less stable and can undergo hydrolysis, especially at elevated temperature or alkaline pH. The anomeric form also matters: beta-NMN is the naturally occurring form, while alpha-NMN can appear as a synthetic impurity. Purity and storage conditions therefore influence both analytical results and experimental reproducibility.
Identity and purity are usually assessed with complementary methods. Nuclear magnetic resonance spectroscopy can confirm the molecular structure and distinguish anomeric forms. High-performance liquid chromatography with ultraviolet detection or mass spectrometry is common for assay and related-substance testing. Mass spectrometry also supports trace quantification in biological samples, often with isotope-labeled internal standards. Because NMN lacks a strong chromophore, some ultraviolet methods require careful wavelength selection or derivatization, and laboratories may validate each approach for its intended matrix.
Stability testing examines how temperature, humidity, light, and pH affect NMN over time. The compound is generally considered hygroscopic and may degrade faster in aqueous solution than in dry powder form. Phosphate esters can hydrolyze under strongly acidic or alkaline conditions, and elevated temperatures accelerate such reactions. For storage, sealed containers at low temperature with desiccant are typical laboratory practices. Stability-indicating methods should separate NMN from its degradation products, including nicotinamide and nicotinamide riboside, so that purity loss can be tracked accurately.
Quality control for NMN materials typically includes identity, assay, impurity, and residual solvent tests. Certificates of analysis may report HPLC purity, water content, heavy metals, and microbial limits depending on the intended use. Because commercial NMN is sold as a research chemical or ingredient rather than a standardized drug in many jurisdictions, specifications can vary between suppliers. Independent verification can involve comparing retention time, mass spectrum, and NMR data against a reference standard. Open questions remain about how best to standardize purity claims and biological potency across different production methods.
Analytical identification of NMN usually combines chromatographic separation with mass spectrometric detection. High-performance liquid chromatography coupled to tandem mass spectrometry is common for quantifying NMN in biological matrices and finished materials. Because NMN and related nucleotides share similar masses and retention behavior, method development must resolve potential interferences such as nicotinamide riboside and NAD+. Ultraviolet detection at approximately 260 nm can be used for purity checks when concentrations are sufficient. Nuclear magnetic resonance spectroscopy provides structural confirmation and can distinguish anomeric forms.
== Public health concerns == Epidemics of fatal pulmonary hypertension and heart valve damage associated with pharmaceutical anorectic agents have led to the withdrawal of products from the market. This was the case with aminorex in the 1960s, and again in the 1990s with fenfluramine (see: Fen-phen). Likewise, association of the related appetite suppressant phenylpropanolamine with hemorrhagic stroke led the Food and Drug Administration (FDA) to request its withdrawal from the market in the United States in 2000, and similar concerns regarding ephedrine resulted in an FDA ban on its inclusion in dietary supplements in 2004. A Federal judge later overturned this ban in 2005 during a challenge by supplement maker Nutraceuticals. It is also debatable as to whether the ephedrine ban had more to do with its use as a precursor in methamphetamine manufacture rather than health concerns with the ingredient as such.
In contrast to these serotonin releasing agents however, mCPP does not appear to cause long-term serotonin depletion (a property thought to be related to serotonergic neurotoxicity). Trazodone's 5-HT2A receptor antagonism and weak serotonin reuptake inhibition form the basis of its common label as an antidepressant of the serotonin antagonist and reuptake inhibitor (SARI) type.
Prior to the US naval deployment, Richard Grenell, Trump's special envoy to Venezuela, had been working towards a deal with Maduro's administration. After extended talks, Maduro's aides had reportedly offered American companies preference in contracts and access to all oil and gold ventures within the country, and to sharply reduce export ties with China, Iran, and Russia. Maduro knew that "loosening those alliances was an inevitable price for avoiding American military intervention", a source told The New York Times. Some concessions were made as talks continued; in May 2025, Venezuela agreed to release Joseph St. Clair, a US Air Force veteran who had been "wrongfully detained" by Venezuelan security forces, according to the US State Department. Chevron's license to operate in Venezuela under US sanctions, revoked by Trump in February, was reinstated in July 2025. Preliminary efforts to allow Shell to restart work in Venezuela also began. Rubio strongly opposed Grenell's "resource diplomacy" approach, stating that "Chevron's continued operations in Venezuela legitimize and enable Maduro's grip on power". On 6 October, Trump directed Grenell to shut down all diplomatic talks with Venezuela amid growing tensions and frustrations with Venezuelan political dialogue. Since at least April 2025, Qatar had acted as a political go-between, attempting to maintain communications between the two nations through back-channel diplomacy.
A D-peptide is a short sequence of D-amino acids connected by peptide bonds. Since ribosomes are specific to L-amino acids, the vast majority of naturally occurring peptides and proteins are composed of L-amino acids. One exception are the D-peptides in the peptidoglycan of bacterial cell walls. D-peptides rarely occur naturally in organisms and are not easily digested or degraded. D-peptide peptidomimetics are D-peptides designed to mimic natural L-peptides that commonly have therapeutic properties. A peptide with secondary structure cannot be mimicked by its retro-inverse, as linking in the reverse order breaks many backbone interactions essential for the secondary structure. An approach to mimicking these peptides is by searching for similar (sidechain) structures in a mirrored copy of the Protein Data Bank for the structured elements, and then linking the sections by retro-inversed versions of the loops found in the original protein.
There are many species of bacteria and other microorganisms that live on or inside the average healthy human body. In fact, there are roughly as many microbial as human cells in the human body by number. (much less by mass or volume). Some of these symbionts are necessary for our health. Those that neither help nor harm humans are called commensal organisms.
Sources: en.wikipedia.org
Benzodiazepines have robust efficacy in the short-term management of generalized anxiety disorder (GAD) when standardized measures of anxiety are used as the outcome variable, but did not demonstrate a favorable dropout rate compared to placebo in one meta-analysis. A newer meta-analysis showed that benzodiazepines are significantly more effective than serotonergic agents, regardless of treatment length. More research is needed, but unfortunately, newer randomized controlled trials are scarce for the off patent benzodiazepines. According to National Institute for Health and Clinical Excellence (NICE), benzodiazepines can be used in the immediate management of GAD, if necessary. However, they should not usually be given for longer than 2–4 weeks. The only medications NICE recommends for the longer-term management of GAD are antidepressants. Likewise, the Canadian Psychiatric Association (CPA) recommends benzodiazepines alprazolam, bromazepam, lorazepam, and diazepam only as a second-line choice, if the treatment with two different antidepressants was unsuccessful. Although they are second-line agents, benzodiazepines can be used for a limited time to relieve severe anxiety and agitation. CPA guidelines state that after 4–6 weeks the effect of benzodiazepines may decrease to the level of placebo, and that benzodiazepines are less effective than antidepressants in alleviating ruminative worry, the core symptom of GAD, but that in some cases, a prolonged treatment with benzodiazepines as the add-on to an antidepressant may be justified.
Duterte has been described as a populist, with his foul-mouthed remarks against the country's elite which positioned him as a "man of the people" and was critical to his victory in the 2016 presidential election. He has also been compared to U.S. President Donald Trump for his rhetorical style. Duterte and his administration have been criticized for his anti-drug campaign, foreign policies, human rights record, extrajudicial killings during his term, political views, and controversial comments. Despite the criticisms on his administration, throughout his career, Duterte's remained hugely popular, attributed to his man-of-the-people style and a perception of strong leadership and success in fighting crime and corruption, while opponents reproach him for his authoritarian style and low tolerance of dissent. Analysts attribute his continued popularity to his emotional connection to the public, citing his charisma and humor, tough-talking manner, his image as a father figure as Tatay Digong (Father Digong), and Filipinos' general interest in strong leaders. A Social Weather Stations study concluded that there are multiple reasons for Duterte's high satisfaction ratings in surveys; these include his strong base support, satisfaction with the administration's overall governance (pamamalakad) and with some policy issues which include helping the poor and the drug war, and his character. Poll respondents who relate to or are attracted to some aspects of his character, such as his perceived decisiveness and diligence tend to be satisfied.
The British governor Stamford Raffles arrived in Singapore on 28 January 1819 and soon recognised the island as a natural choice for the new port. The island was then nominally ruled by Tengku Abdul Rahman, the Sultan of Johor, who was controlled by the Dutch and the Bugis. However, the Sultanate was weakened by factional division: Abdul Rahman, the Temenggong of Johor to Tengku Abdul Rahman, as well as his officials, were loyal to the Sultan's elder brother Tengku Long, who was living in exile in Penyengat Island, Riau Islands. With the Temenggong's help, Raffles managed to smuggle Tengku Long back into Singapore. Raffles offered to recognise Tengku Long as the rightful Sultan of Johor, under the title of Sultan Hussein, as well as provide him with a yearly payment of $5000 and another $3000 to the Temenggong; in return, Sultan Hussein would grant the British the right to establish a trading post on Singapore. The Treaty of Singapore was signed on 6 February 1819. In 1824, a further treaty with the Sultan led to the entire island becoming a part of the British Empire. In 1826, Singapore became part of the Straits Settlements, then under the jurisdiction of British India. Singapore became the regional capital in 1836. Prior to Raffles' arrival, there were only about a thousand people living on the island, mostly indigenous Malays along with a handful of Chinese. By 1860 the population had swelled to over 80,000, more than half being Chinese. Many of these early immigrants came to work on the pepper and gambier plantations.
== Further reading == Baena-Cagnani CE (2001). "Desloratadine activity in concurrent seasonal allergic rhinitis and asthma". Allergy. 56 Suppl 65: 21–7. doi:10.1111/j.1398-9995.2001.00001.x-i1. PMID 11243501. Devillier P, Roche N, Faisy C (2008). "Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review". Clinical Pharmacokinetics. 47 (4): 217–30. doi:10.2165/00003088-200847040-00001. PMID 18336052. Geha RS, Meltzer EO (April 2001). "Desloratadine: A new, nonsedating, oral antihistamine". The Journal of Allergy and Clinical Immunology. 107 (4): 751–62. doi:10.1067/mai.2001.114239. PMID 11295678. Henz BM (2001). "The pharmacologic profile of desloratadine: a review". Allergy. 56 Suppl 65: 7–13. doi:10.1034/j.1398-9995.2001.00101.x. PMID 11243504.
The development of microbial therapeutics is an active area of research in microbiology and synthetic biology. Researchers generally follow two main approaches. One approach focuses on identifying naturally occurring microorganisms that already have beneficial effects on human health and studying how they can be safely used as treatments. The second approach involves genetically engineering microorganisms to give them new or enhanced therapeutic functions, such as producing specific medicines inside the body or responding to changes in the disease environment. Developing microbial therapeutics also involves addressing challenges related to safety, stability, and control. Scientists work to ensure that therapeutic microbes behave predictably, can be reliably manufactured, and remain effective without causing harm to patients.
Sources: en.wikipedia.org
=== Regulatory approval === Lurasidone was approved in the United States for the treatment of schizophrenia in October 2010 and for the treatment of depressive episodes associated with bipolar I disorder in June 2013. In 2015, lurasidone was studied for major depressive disorder with mixed features in a randomized trial and had a positive result, however it did not receive an FDA indication for it. In 2017, the FDA approved lurasidone for schizophrenia in adolescents age 13-17. In 2018, lurasidone was approved for bipolar depression in children and adolescents age 10-17. It received regulatory approval in the United Kingdom in September 2014. In October 2014, NHS Scotland advised use of lurasidone for schizophrenic adults who have not seen improvements with previous antipsychotics due to problems that arise from weight gain or changes in metabolic pathways when taking other medications. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for it in January 2014, and it was approved for medical use by the EMA in March 2014. It was launched in Canada for the treatment of schizophrenia in September 2012, Health Canada giving their Summary Basis of Decision (SBD) as favourable on 15 October 2012. The European Commission has granted a marketing authorization for once-daily oral lurasidone for the treatment of schizophrenia in adults. It is approved for use in the EU. Generic versions of lurasidone were approved for use in the United States in January 2019 and became available in 2023.
=== European Union === Hitchens was a supporter of the European Union. In an appearance on C-SPAN in 1993, Hitchens said, "As of 1992, there is a now a Euro passport that makes you free to travel within the boundaries of... member countries, and I've always liked the idea of European unity, and so I held out for a Euro passport. So I travel as a European." Speaking at the launch of his brother Peter Hitchens' book, The Abolition of Britain at Conway Hall in London, Hitchens denounced the so-called Eurosceptic movement, describing it as "the British version of fascism". He went on to say, "Scepticism is a title of honour. These people are not sceptical. They're fanatical. They're dogmatic".
Fe(II) + H2O2 → Fe(III)OH + HO· The Fenton reaction explains the toxicity of hydrogen peroxides because the hydroxyl radicals rapidly and irreversibly oxidize all organic compounds, including proteins, membrane lipids, and DNA. Hydrogen peroxide is a significant source of oxidative DNA damage in living cells. DNA damage includes formation of 8-Oxo-2'-deoxyguanosine among many other altered bases, as well as strand breaks, inter-strand crosslinks, and deoxyribose damage. By interacting with Cl−, hydrogen peroxide also leads to chlorinated DNA bases. Hydroxyl radicals readily damage vital cellular components, especially those of the mitochondria. The compound is a major factor implicated in the free-radical theory of aging, based on its ready conversion into a hydroxyl radical.
== About == CoWIN serves the function of registration, appointment scheduling, identity verification, vaccination and certification of each vaccinated member. Registration for the vaccination slots can be booked on the same day or a few days prior. The platform has also been integrated in the Aarogya Setu and UMANG Apps. The certificate after COVID-19 vaccination can also be obtained through the platform. To expedite the development of this platform, several existing digital assets were leveraged, such as: Electronic Vaccine Intelligence Network (eVIN), Digital Infrastructure for Vaccination Open Credentialing (DIVOC), DigiLocker, Surveillance and Action for Events Following Vaccination (SAFE-VAC). CoWIN application was developed with five modules: the orchestration module; the vaccination cold chain module; the citizen registration module; the vaccinator module; and the certificate, feedback, and adverse event following immunization reporting module. As of now, eight vaccines can be registered on the platform in the country Covishield (18+), Covaxin (15+), Corbevax (12-14), Sputnik V (18+), Corbevax (12-14), Gemcovac (18+) Incovacc (18+), ZyCoV-D (18+) and Covovax (12+). In the future, the Health ministry is working on upgrading CoWIN for the effective implementation of India's universal immunization programme. Co-WIN platform will be used for booking slots for the routine vaccinations like Polio and Hepatitis.
Sources: en.wikipedia.org
Solid NMN is generally stored in a sealed container at -20 °C or below, protected from light and moisture. Some suppliers recommend a desiccant and inert gas. Aqueous solutions are less stable and are often prepared fresh.
Liquid chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy are common identity tests. HPLC with ultraviolet detection can assess purity by peak area. Results are usually compared with a certified reference standard.
Degradation can reduce the amount of intact NMN and create related impurities. Storage conditions and handling therefore affect measured purity and experimental reproducibility. Stability data also inform labeling and shelf-life claims.
Liquid chromatography with tandem mass spectrometry is common because it can quantify low levels of NMN in complex samples. High-performance liquid chromatography with ultraviolet detection is used for simpler purity checks. Nuclear magnetic resonance can confirm identity and detect some impurities.